The result indicated that HTR1A was expressed at low levels in ovarian serous cystadenocarcinoma (OV) and glioblastoma multiforme (GBM) while being highly expressed in brain lower grade glioma (LGG) (Figure 3A). This evidence concerns the gene HTR1A and ovarian serous cystadenocarcinoma.